| Jose Gabriel Improvola, MD | |
|
2325 18th St, Suite 130, Columbus, IN 47201-5388 | |
| (812) 379-2020 | |
| Not Available |
| Full Name | Jose Gabriel Improvola |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 2325 18th St, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164749701 | NPI | - | NPPES |
| 000000990788 | Other | IN | ANTHEM PIN |
| 2565399 | Medicaid | OH | |
| 201229440 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda North | Cincinnati, OH | Hospital |
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| Mccullough-hyde Memorial Hospital | Oxford, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth H Llc | 1850570458 | 668 |
News Archive
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.
Many family characteristics are predictors of youth runaway behavior, as determined in a new study released today by the National Runaway Safeline (NRS), a 24/7 hotline and online services for runaway, homeless and at-risk youth.
› Verified 4 days ago
| Entity Name | Trihealth G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.
Many family characteristics are predictors of youth runaway behavior, as determined in a new study released today by the National Runaway Safeline (NRS), a 24/7 hotline and online services for runaway, homeless and at-risk youth.
› Verified 4 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.
Many family characteristics are predictors of youth runaway behavior, as determined in a new study released today by the National Runaway Safeline (NRS), a 24/7 hotline and online services for runaway, homeless and at-risk youth.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose Gabriel Improvola, MD 2325 18th St, Suite 130, Columbus, IN 47201-5388 Ph: (812) 379-2020 | Jose Gabriel Improvola, MD 2325 18th St, Suite 130, Columbus, IN 47201-5388 Ph: (812) 379-2020 |
News Archive
The Rochester General Hospital Research Institute has been awarded a $7.1 million grant to study the effectiveness of a new vaccine on the bacteria that cause ear infections in children. Michael E. Pichichero MD, Director of the Research Institute, has been named Principal Investigator of the five year study which will follow children who receive the Prevnar 13 vaccine. The vaccine is manufactured by Pfizer Vaccine Research of Collegeville, Pennsylvania which is funding the grant.
In a recent study, researchers study the molecular aspects of SARS-CoV-2 host cell entry and inhibition of host-specific cellular mechanisms.
Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.
A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.
Many family characteristics are predictors of youth runaway behavior, as determined in a new study released today by the National Runaway Safeline (NRS), a 24/7 hotline and online services for runaway, homeless and at-risk youth.
› Verified 4 days ago
Melissa Andrea Martinez Mateo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2326 18th St Ste 210, Columbus, IN 47201 Phone: 812-372-8680 | |
Vatsal Bajpai, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 | |
Neil Amin, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 | |
Dr. Nandu Gourineni, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Lawrence Klein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Chelsie Lynn Brady, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Brian M Kline, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 815 Schnier St, Columbus, IN 47201 Phone: 912-375-8810 |